OMER Share Price

Open 11.10 Change Price %
High 11.41 1 Day -0.35 -3.21
Low 10.48 1 Week -1.83 -14.77
Close 10.56 1 Month 0.84 8.64
Volume 816452 1 Year -5.65 -34.86
52 Week High 16.80
52 Week Low 7.20
OMER Important Levels
Resistance 2 11.42
Resistance 1 11.07
Pivot 10.82
Support 1 10.05
Support 2 9.70
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SIRI 4.33 0.70%
SUSQ 14.20 -0.77%
AAPL 109.10 -0.73%
AAPL 109.10 -0.73%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LLEN 0.03 50.00%
LOCM 0.09 50.00%
RITT 0.09 50.00%
MEMP 0.64 33.33%
SKBI 0.19 26.67%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CLNT 0.88 23.94%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LIWA 0.01 -50.00%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Omeros Corporation (NASDAQ: OMER)

OMER Technical Analysis 1.5
As on 5th Dec 2016 OMER Share Price closed @ 10.56 and we RECOMMEND Sell for LONG-TERM with Stoploss of 11.61 & Buy for SHORT-TERM with Stoploss of 10.39 we also expect STOCK to react on Following IMPORTANT LEVELS.
OMER Target for December
1st Target up-side 15.61
2nd Target up-side 17.94
3rd Target up-side 20.26
1st Target down-side 8.97
2nd Target down-side 6.64
3rd Target down-side 4.32
OMER Other Details
Segment EQ
Market Capital 234317888.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.omeros.com
OMER Address
OMER
201 Elliott Avenue West
Seattle, WA 98119
United States
Phone: 206-676-5000
Fax: 206-676-5005
Interactive Technical Analysis Chart Omeros Corporation ( OMER NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Omeros Corporation
OMER Business Profile
Omeros Corporation operates as a biopharmaceutical company focused on the discovery, development and commercialization of products focused on inflammation and disorders of the central nervous system. The Company develops pharmaceutical and therapeutic approaches to the management of surgical pain and inflammation, vasospasm, smooth muscle spasm, vascular restenosis and implantable surgical devices. Omeros develops products that are delivered directly to the site of tissue injury, preemptively inhibiting inflammation, pain and other problems associated with medical and surgical procedures.